CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Dec. 31, 2015	Dec. 31, 2014
Current assets:
Cash and cash equivalents	$ 267.1	$ 319.5
Short-term investments	201.2	178.0
Accounts receivable, net	234.7	293.2
Inventories	422.0	477.4
Deferred tax assets		9.3
Other current assets	106.6	88.9
Total current assets	1,231.6	1,366.3
Property, plant and equipment, net	231.1	249.9
Goodwill	130.6	127.8
Intangible assets, net	74.7	83.8
Deferred tax assets	53.0	29.7
Other long-term assets	9.9	7.3
Total assets	1,730.9	1,864.8
Current liabilities:
Current portion of long-term debt	0.7	0.8
Accounts payable	72.1	76.0
Customer advances	178.3	189.5
Deferred tax liabilities		15.0
Other current liabilities	303.5	301.4
Total current liabilities	554.6	582.7
Long-term debt	266.0	354.2
Long-term deferred revenue	44.4	37.1
Deferred tax liabilities	9.5	17.8
Accrued pension	91.6	66.2
Other long-term liabilities	$ 31.9	$ 35.1
Commitments and contingencies (Note 14)
Shareholders' equity:
Preferred stock, $0.01 par value 5,000,000 shares authorized, none issued or outstanding at December 31, 2015 and 2014
Common stock, $0.01 par value 260,000,000 shares authorized, 169,644,644 and 168,582,988 shares issued and 165,354,180 and 168,527,584 outstanding at December 31, 2015 and 2014, respectively	$ 1.7	$ 1.7
Treasury stock at cost, 4,290,527 and 55,404 shares at December 31, 2015 and 2014, respectively	(90.9)	(0.9)
Additional paid-in capital	102.1	81.1
Retained earnings	757.4	655.8
Accumulated other comprehensive income (loss)	(44.2)	28.2
Total shareholders' equity attributable to Bruker Corporation	726.1	765.9
Noncontrolling interest in consolidated subsidiaries	6.8	5.8
Total shareholders' equity	732.9	771.7
Total liabilities and shareholders' equity	$ 1,730.9	$ 1,864.8